
Akihide Yoshimi
@akihideyoshimi
Studying Aberrant RNA Splicing in Cancers, Chief @YoshimiLab (Div. Cancer RNA Research), NCC Japan @NccriOfficial, MD, PhD, Lab website⬇️
ID: 892507798730399745
https://www.ncc.go.jp/en/ri/division/cancer_rna/index.html 01-08-2017 22:10:16
499 Tweet
229 Takipçi
305 Takip Edilen






Journal Club-84 Molecular Cell High-throughput analysis of ~700 transcription factor (TF) isoforms demonstrated the molecular functional diversification conferred by TF alternative isoforms. Furthermore, differences in IDR (intrinsically disordered regions) -flexible structural

Journal Club-84 Molecular Cell 240種類以上の転写因子(TF)のisoform 約700種類を対象にisoforms間で網羅的解析を行い、TF isoformsがもたらす分子作用の多様化を明らかにした。加えて、TFの持つ主要ドメイン以外の領域で、柔軟な構造をとるIDR (intrinsically disordered

Mina Yoshida presented a poster at #RNA25 meeting of the The RNA Society in San Diego. 吉田澪奈さんがThe 30th Annual Meeting of the RNA Society in San Diegoでposter発表をしました。










Akihide Yoshimi gave an invited lecture at the 15AGW (15th International Workshop on Advanced Genomics). Thank you for the invitation‼️ 吉見昭秀さんが第15回国際ゲノム会議で招待講演しました。お招き頂きありがとうございました😊 pac-mice.jp/15agw/

Journal Club-88 Science Magazine 標的指向性LNPにより、in vivoでCD8+ T細胞にCD19-CARを選択的に発現させる手法が開発された。In vivoでの遺伝子導入で高効率にCD8+ T細胞のCAR発現が確認され、さらに脾臓やリンパ節も含めた広範な一過性のB細胞除去(immune

Journal Club-88 Science Magazine A targeted LNP platform was developed to preferentially induce CD19-CAR expression in CD8⁺ T cells in vivo. High-efficiency CAR expression in CD8⁺ T cells was confirmed through the in vivo gene delivery. Moreover, broad and transient B cell
